Coronary Artery Disease Pipeline, Clinical Trials, NDA Approvals (2023) | Companies - Idorsia Pharmaceuticals, AstraZeneca, Sinotau Pharmaceuticals, XyloCor Therapeutics, and others
M2 Presswire, 2023-06-22
COPYRIGHT 2023 Normans Media Ltd.
Digital Resources/Online E-Resources